Total Payments
$12,648
2024 Payments
$1,495
Companies
9
Transactions
24
Medicare Patients
4,651
Medicare Billing
$1.0M
Payment Breakdown by Category
Consulting$9,400 (74.3%)
Travel$2,226 (17.6%)
Food & Beverage$1,022 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,400 | 3 | 74.3% |
| Travel and Lodging | $2,226 | 10 | 17.6% |
| Food and Beverage | $1,022 | 11 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $8,041 | 6 | $0 (2023) |
| Genentech, Inc. | $1,650 | 1 | $0 (2022) |
| Alcon Vision LLC | $1,426 | 6 | $0 (2024) |
| Spark Therapeutics, Inc. | $1,078 | 5 | $0 (2024) |
| Dutch Ophthalmic, USA | $175.85 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $125.13 | 2 | $0 (2019) |
| Allergan Inc. | $119.75 | 1 | $0 (2019) |
| Genentech USA, Inc. | $21.58 | 1 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $11.79 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,495 | 7 | Spark Therapeutics, Inc. ($1,078) |
| 2023 | $8,217 | 7 | AbbVie Inc. ($8,041) |
| 2022 | $1,650 | 1 | Genentech, Inc. ($1,650) |
| 2021 | $21.58 | 1 | Genentech USA, Inc. ($21.58) |
| 2019 | $1,265 | 8 | Alcon Vision LLC ($1,008) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $224.94 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $192.61 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | In-kind items and services | $722.20 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | In-kind items and services | $187.28 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Travel and Lodging | Cash or cash equivalent | $85.57 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $42.51 | General |
| Category: OCULAR | ||||||
| 05/28/2024 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: OCULAR | ||||||
| 11/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $6,200.00 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $105.80 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $103.49 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: EYE CARE | ||||||
| 07/28/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $175.85 | General |
| Category: Ophthalmology | ||||||
| 05/08/2023 | AbbVie Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $1,550.00 | General |
| Category: EYE CARE | ||||||
| 04/13/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: EYE CARE | ||||||
| 03/12/2022 | Genentech, Inc. | VABYSMO (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/19/2021 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 11/22/2019 | Alcon Vision LLC | DAILIES (Device) | Travel and Lodging | Cash or cash equivalent | $499.00 | General |
| Category: Ophthalmology | ||||||
| 11/22/2019 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $238.55 | General |
| 11/22/2019 | Alcon Vision LLC | — | Travel and Lodging | Cash or cash equivalent | $194.46 | General |
| 11/22/2019 | Alcon Vision LLC | — | Travel and Lodging | Cash or cash equivalent | $76.07 | General |
| 11/01/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $109.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/04/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.79 | General |
| Category: AED | ||||||
| 08/14/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $119.75 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,537 | 2,815 | $2.2M | $325,889 |
| 2022 | 15 | 1,466 | 2,601 | $2.5M | $389,559 |
| 2021 | 14 | 832 | 996 | $465,389 | $154,616 |
| 2020 | 19 | 816 | 977 | $480,546 | $134,340 |
Total Patients
4,651
Total Services
7,389
Medicare Billing
$1.0M
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 37 | 202 | $508,669 | $138,799 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 466 | $137,804 | $43,315 | 31.4% |
| 67028 | Injection of drug into eye | Facility | 2023 | 355 | 518 | $585,387 | $36,844 | 6.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 27 | 27 | $239,463 | $23,786 | 9.9% |
| 92134 | Imaging of retina | Office | 2023 | 386 | 748 | $167,185 | $22,018 | 13.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 93 | 222 | $257,482 | $20,811 | 8.1% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2023 | 15 | 15 | $116,460 | $11,089 | 9.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 53 | 155 | $57,700 | $8,374 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 115 | $21,866 | $6,915 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $24,190 | $6,113 | 25.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 52 | 52 | $27,924 | $5,628 | 20.2% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 16 | 37 | $19,715 | $1,250 | 6.3% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 17 | 23 | $2,415 | $615.56 | 25.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 16 | 16 | $3,536 | $222.65 | 6.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 144 | $2,491 | $108.14 | 4.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 39 | 276 | $696,900 | $197,355 | 28.3% |
| 67028 | Injection of drug into eye | Facility | 2022 | 386 | 585 | $690,004 | $42,569 | 6.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 321 | $94,014 | $30,189 | 32.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 89 | 233 | $271,684 | $22,468 | 8.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 23 | 24 | $205,656 | $21,522 | 10.5% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2022 | 27 | 28 | $210,028 | $20,230 | 9.6% |
| 92134 | Imaging of retina | Office | 2022 | 336 | 565 | $126,664 | $17,359 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 102 | 102 | $48,440 | $12,227 | 25.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 54 | 142 | $59,214 | $7,527 | 12.7% |
| 66986 | Exchange of prosthetic lens | Facility | 2022 | 15 | 15 | $36,312 | $5,982 | 16.5% |
About Dr. Matthew Starr, M.D
Dr. Matthew Starr, M.D is a Ophthalmology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1972982262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Starr, M.D has received a total of $12,648 in payments from pharmaceutical and medical device companies, with $1,495 received in 2024. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($9,400).
As a Medicare-enrolled provider, Starr has provided services to 4,651 Medicare beneficiaries, totaling 7,389 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Rochester, MN
- Active Since 05/20/2015
- Last Updated 07/22/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1972982262
Products in Payments
- OZURDEX (Drug) $8,161
- VABYSMO (Drug) $1,650
- LUXTURNA (Biological) $1,078
- DAILIES (Device) $499.00
- EVA, combined machine (Device) $175.85
- EYLEA (Biological) $125.13
- OXTELLAR XR (Drug) $11.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Rochester
Paul Hartman, Md, MD
Ophthalmology — Payments: $355,012
Ophthalmology $355,012
Malav Joshi, M.d, M.D
Ophthalmology — Payments: $295,274
Ophthalmology $295,274
Sophie Bakri, M.d, M.D
Ophthalmology — Payments: $268,408
Ophthalmology $268,408
Dr. Matthew Witmer, Md, MD
Ophthalmology — Payments: $79,590
Ophthalmology $79,590
Dr. Scott Macrae, M.d, M.D
Ophthalmology — Payments: $74,108
Ophthalmology $74,108
Dr. Muhammad Bhatti, Md, MD
Ophthalmology — Payments: $55,971
Ophthalmology $55,971